CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 304 enrolled
Drug / intervention
Endoluminal treament of thoracic lesionsdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00597870
NCT00597870N/ACompleted
CompareCT.gov

Physician-Sponsored IDE for the Talent Endoluminal Stent Graft System for the Treatment of Thoracic Lesions

Rodney A. White, M.D.·interventional·Posted Jan 18, 2008·Updated Sep 14, 2023

In Brief

A clinical study evaluating Endoluminal treament of thoracic lesions for Thoracic Aortic Aneurysms and 4 related conditions. Completed, enrolled 304 participants across 1 site.

Detailed Summary

The primary objective of this trial is to determine whether the Talent Thoracic Stent Graft, an investigational device, is a safe and effective method of treating thoracic aortic aneurysms (abnormal ballooning of the vessel wall) and other thoracic lesions (dissections, transections, pseudoaneurysms, penetrating ulcers, etc.). The endovascular method is a substitute for the major operation that is performed to treat the lesions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsThoracic Aortic Aneurysms, Thoracic Transections, Intramural Hematoma, Pseudoaneurysm, Thoracic Aortic Dissection
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 18, 2008
Enrollment StartMay 1, 2002
Primary CompletionJan 1, 2021
TodayJul 2, 2026
Enrollment to primary: 18.7 yearsPosted 18.5 years ago

Interventions

Endoluminal treament of thoracic lesionsdevice

Endoluminal treament of thoracic lesions with a thoracic stent-graft